Newswise — Washington, D.C., March 22, 2021 – MedStar Heart & Vascular Institute is pleased to announce that Abeel A. Mangi, MD, has joined its leadership team as the MedStar Health System Chair of Cardiac Surgery. A highly accomplished cardiothoracic surgeon, Dr. Mangi brings a distinguished record of clinical competency and expertise to MedStar Health.
Dr. Mangi joins MedStar Heart & Vascular Institute from the Yale New Haven Heart and Vascular Center where he served as the surgical director of the structural heart and cardiac valve program and managing director of the cardiac surgery network. He also served as Professor of Surgery at the Yale University School of Medicine.
“As a proven leader in cardiac surgery, Dr. Mangi is exceptionally well-qualified to build upon MedStar Heart & Vascular Institute’s outstanding legacy in cardiac surgery,” said Stuart F. Seides, MD, physician executive director, MedStar Heart & Vascular Institute. “His record of collaborative and visionary leadership will foster the continued upward trajectory of our program, further broadening its well-established national and international recognition.”
Dr. Mangi specializes in complex and re-operative cardiac surgery, aortic and mitral valve repair and replacement, arterial coronary revascularization, transcatheter valve repair and replacement, and ascending aorta and aortic arch replacement. He is a member of numerous societies, including the International Society for Heart and Lung Transplantation, the American College of Cardiology, The Society for Thoracic Surgeons, the Society of University Surgeons, and the American College of Surgeons. He has led 40 clinical trials and grants and authored and co-authored more than 200 publications.
Dr. Mangi earned his undergraduate and medical degrees from Brown University. After completing his residency in general surgery at the Massachusetts General Hospital and Harvard Medical School, he was awarded a postdoctoral National Research Service Award fellowship from the National Institutes of Health and was recognized by the American College of Cardiology for ground-breaking stem cell research. He completed his fellowship in cardiac surgery and an advanced fellowship in mechanical circulatory support and cardiac transplantation at New York-Presbyterian Medical Center and Columbia University. He also earned a master’s degree in business administration from the Sloan School of Management at the Massachusetts Institute of Technology.
MedStar Heart & Vascular Institute, founded at MedStar Washington Hospital Center in Washington, D.C., is a national leader in the research, diagnosis, and treatment of cardiovascular disease, and has been recognized by U.S. News & World Report and The Society of Thoracic Surgeons as one of the top cardiovascular programs in the nation. It is comprised of a network of 10 hospitals and 175 cardiovascular physicians located throughout Maryland, Northern Virginia and the Greater Washington, D.C., region. MedStar Heart & Vascular Institute’s cardiac surgery program is one of the busiest and best regarded in the mid-Atlantic region with more than 2,200 surgeries performed annually. It is among the top five centers in the country for Ventricular Assist Device (VAD) implantation, and 29 heart transplants were performed in 2020, making it one of the most active circulatory support centers in the nation.